Author:
Busse William W.,Kraft Monica
Abstract
Despite the availability of effective inhaled therapies, many patients with asthma have poor asthma control. Uncontrolled asthma presents a significant burden on the patient and society, and, for many, remains largely preventable. There are numerous reasons why a patient may remain uncontrolled despite access to therapies, including incorrect inhaler technique, poor adherence to treatment, oversight of triggers and suboptimal medical care. Shared decision-making, good patient–clinician communication, supported self-management, multidisciplinary patient education, new technology and risk stratification may all provide solutions to this major unmet need in asthma. Novel treatments such as biologics could benefit patients’ lives, while the investigations into biomarkers, non-Type 2 asthma, treatable traits and disease modification give an exciting glimpse into the future of asthma care.
Publisher
European Respiratory Society (ERS)
Subject
Pulmonary and Respiratory Medicine
Reference156 articles.
1. Global Initiative for Asthma (GINA) . Global Strategy for Asthma Management and Prevention. 2021. Available from: https://ginasthma.org/
2. One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting beta2-agonist in UK primary care settings;Buhl;Respir Med,2020
3. Royal College of Physicians UK . Why asthma still kills. National Review of Asthma Deaths. www.rcplondon.ac.uk/projects/outputs/why-asthma-still-kills. Date last updated: August 11, 2015. Date last accessed: January 7, 2021.
4. Oral corticosteroid exposure and adverse effects in asthmatic patients
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献